Because intracellular NADPH depletion and consecutive oxidative stress with damaged erythrocytes (hemolysis) is typical for G6PD deficiency, it is not surprising that G6PD deficiency in COVID-19 patients seems to be associated with elevated MetHb and COHb levels [20].